Impact of Mercaptopurine Metabolites on Disease Outcome in the AIEOP-BFM ALL 2009 Protocol for Acute Lymphoblastic Leukemia.
- DOI
- 10.1002/cpt.3022
- Published
- 2023 Nov
- Container
- Clinical pharmacology and therapeutics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cpt.3022,
title = {Impact of Mercaptopurine Metabolites on Disease Outcome in the AIEOP-BFM ALL 2009 Protocol for Acute Lymphoblastic Leukemia.},
author = {Franca R and Stocco G and Kiren V and Tessitore A and Fagioli F and Quarello P and Bertorello N and Rizzari C and Colombini A and Bettini LR and Locatelli F and Vinti L and Girardi K and Silvestri D and Valsecchi MG and Decorti G and Rabusin M},
year = {2023},
journal = {Clinical pharmacology and therapeutics},
doi = {10.1002/cpt.3022},
url = {https://doi.org/10.1002/cpt.3022}
}RIS
TY - JOUR TI - Impact of Mercaptopurine Metabolites on Disease Outcome in the AIEOP-BFM ALL 2009 Protocol for Acute Lymphoblastic Leukemia. AU - Franca R AU - Stocco G AU - Kiren V AU - Tessitore A AU - Fagioli F AU - Quarello P AU - Bertorello N AU - Rizzari C AU - Colombini A AU - Bettini LR AU - Locatelli F AU - Vinti L AU - Girardi K AU - Silvestri D AU - Valsecchi MG AU - Decorti G AU - Rabusin M PY - 2023 JO - Clinical pharmacology and therapeutics DO - 10.1002/cpt.3022 UR - https://doi.org/10.1002/cpt.3022 ER -
APA
R, F., G, S., V, K., A, T., F, F., P, Q., N, B., C, R., A, C., LR, B., F, L., L, V., K, G., D, S., MG, V., G, D., & M, R. (2023). Impact of Mercaptopurine Metabolites on Disease Outcome in the AIEOP-BFM ALL 2009 Protocol for Acute Lymphoblastic Leukemia.. Clinical pharmacology and therapeutics. https://doi.org/10.1002/cpt.3022
Source records
- pubmed · retrieved 2026-09-27T11:43:45.868Z